Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases
- PMID: 23251142
- PMCID: PMC3515933
- DOI: 10.1155/2012/318613
Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases
Abstract
A direct correlation between adequate nutrition and health is a universally accepted truth. The Western lifestyle, with a high intake of simple sugars, saturated fat, and physical inactivity, promotes pathologic conditions. The main adverse consequences range from cardiovascular disease, type 2 diabetes, and metabolic syndrome to several cancers. Dietary components influence tissue homeostasis in multiple ways and many different functional foods have been associated with various health benefits when consumed. Natural products are an important and promising source for drug discovery. Many anti-inflammatory natural products activate peroxisome proliferator-activated receptors (PPAR); therefore, compounds that activate or modulate PPAR-gamma (PPAR-γ) may help to fight all of these pathological conditions. Consequently, the discovery and optimization of novel PPAR-γ agonists and modulators that would display reduced side effects is of great interest. In this paper, we present some of the main naturally derived products studied that exert an influence on metabolism through the activation or modulation of PPAR-γ, and we also present PPAR-γ-related diseases that can be complementarily treated with nutraceutics from functional foods.
Similar articles
-
Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases.Front Pharmacol. 2022 Oct 21;13:991059. doi: 10.3389/fphar.2022.991059. eCollection 2022. Front Pharmacol. 2022. PMID: 36339586 Free PMC article. Review.
-
Safety issues and prospects for future generations of PPAR modulators.Biochim Biophys Acta. 2007 Aug;1771(8):1065-81. doi: 10.1016/j.bbalip.2007.02.003. Epub 2007 Feb 24. Biochim Biophys Acta. 2007. PMID: 17428730 Review.
-
Evolution of peroxisome proliferator-activated receptor agonists.Ann Pharmacother. 2007 Jun;41(6):973-83. doi: 10.1345/aph.1K013. Epub 2007 May 22. Ann Pharmacother. 2007. PMID: 17519293 Review.
-
Role of PPAR in cardiovascular diseases.Recent Pat Cardiovasc Drug Discov. 2006 Jun;1(2):193-209. doi: 10.2174/157489006777442441. Recent Pat Cardiovasc Drug Discov. 2006. PMID: 18221086 Review.
-
Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.Ann N Y Acad Sci. 2006 Nov;1083:306-18. doi: 10.1196/annals.1367.019. Ann N Y Acad Sci. 2006. PMID: 17148746 Review.
Cited by
-
Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions.Int J Mol Sci. 2021 Nov 18;22(22):12463. doi: 10.3390/ijms222212463. Int J Mol Sci. 2021. PMID: 34830341 Free PMC article. Review.
-
Extracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice.PLoS One. 2013 Nov 29;8(11):e81724. doi: 10.1371/journal.pone.0081724. eCollection 2013. PLoS One. 2013. PMID: 24312343 Free PMC article.
-
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma.J Nat Prod. 2014 Apr 25;77(4):842-7. doi: 10.1021/np400943b. Epub 2014 Mar 5. J Nat Prod. 2014. PMID: 24597776 Free PMC article.
-
Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments.PPAR Res. 2022 Aug 31;2022:4714914. doi: 10.1155/2022/4714914. eCollection 2022. PPAR Res. 2022. PMID: 36092543 Free PMC article. Review.
-
Crosstalk between gut microbiota and antidiabetic drug action.World J Diabetes. 2019 Mar 15;10(3):154-168. doi: 10.4239/wjd.v10.i3.154. World J Diabetes. 2019. PMID: 30891151 Free PMC article. Review.
References
-
- Desvergne B, Michalik L, Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Molecular Endocrinology. 2004;18(6):1321–1332. - PubMed
-
- Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research. 2006;45(2):120–159. - PubMed
-
- Tontonoz P, Singer S, Forman BM, et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(1):237–241. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources